Biotech Bankruptcies Hit Recent High in 2019
Bankruptcies reached a high not seen since 2011, with opioid lawsuits playing a big role.
Mallinckrodt
MNK
MNK
$4.49
-$0.44
-8.9%
Price as of February 14, 2020, 4:15 p.m. EST
View Interactive MNK Charts
Mallinckrodt plc Ordinary Shares
News & Analysis: Mallinckrodt
The Fool has written over 100 articles on Mallinckrodt.
3 Big Winners From the "Super Bowl of Healthcare"
These stocks skyrocketed during healthcare's biggest event of the year -- the J.P. Morgan Healthcare Conference.
Why Mallinckrodt Stock Is Jumping Today
Momentum from its CEO's comments earlier this week continues.
Why Mallinckrodt Stock Is Soaring Today
Investors appear to be optimistic about the drugmaker's impending Q3 update.
Here's Why Mallinckrodt Fell as Much as 14% Today
Investors continue to grapple with the uncertainty hanging over the company.
Why State Street, Mallinckrodt, and ArcelorMittal Jumped Today
Upbeat news on interest rates and asset sales lifted these stocks on an otherwise tough day for the market.
Here's Why Mallinckrodt Is Collapsing Today
The company is reportedly considering bankruptcy to cope with its financial exposure in the opioid crisis.
Why Mallinckrodt Stock Is Plunging Today
Worries about opioid litigation and a recent patent lawsuit loss continue to weigh on the drugmaker.
Why J.M. Smucker, Mallinckrodt, and Lancaster Colony Slumped Today
Find out how earnings affected some of these stocks.
Here's Why Mallinckrodt Fell Over 17% Today
The bad news keeps piling up.
